Literature DB >> 22940644

Genetics: The MAPT locus-a genetic paradigm in disease susceptibility.

Richard Wade-Martins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22940644     DOI： 10.1038/nrneurol.2012.169

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  A common inversion under selection in Europeans.

Authors:  Hreinn Stefansson; Agnar Helgason; Gudmar Thorleifsson; Valgerdur Steinthorsdottir; Gisli Masson; John Barnard; Adam Baker; Aslaug Jonasdottir; Andres Ingason; Vala G Gudnadottir; Natasa Desnica; Andrew Hicks; Arnaldur Gylfason; Daniel F Gudbjartsson; Gudrun M Jonsdottir; Jesus Sainz; Kari Agnarsson; Birgitta Birgisdottir; Shyamali Ghosh; Adalheidur Olafsdottir; Jean-Baptiste Cazier; Kristleifur Kristjansson; Michael L Frigge; Thorgeir E Thorgeirsson; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2005-01-16       Impact factor: 38.330

2.  Tau isoform composition influences rate and extent of filament formation.

Authors:  Qi Zhong; Erin E Congdon; Haikady N Nagaraja; Jeff Kuret
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

3.  Differential regulation of dynein and kinesin motor proteins by tau.

Authors:  Ram Dixit; Jennifer L Ross; Yale E Goldman; Erika L F Holzbaur
Journal:  Science       Date:  2008-01-17       Impact factor: 47.728

4.  Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

Authors:  Lars M Ittner; Yazi D Ke; Fabien Delerue; Mian Bi; Amadeus Gladbach; Janet van Eersel; Heidrun Wölfing; Billy C Chieng; MacDonald J Christie; Ian A Napier; Anne Eckert; Matthias Staufenbiel; Edna Hardeman; Jürgen Götz
Journal:  Cell       Date:  2010-07-22       Impact factor: 41.582

5.  Haplotype-specific expression of exon 10 at the human MAPT locus.

Authors:  Tara M Caffrey; Catharine Joachim; Silvia Paracchini; Margaret M Esiri; Richard Wade-Martins
Journal:  Hum Mol Genet       Date:  2006-11-03       Impact factor: 6.150

6.  Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.

Authors:  Günter U Höglinger; Nadine M Melhem; Dennis W Dickson; Patrick M A Sleiman; Li-San Wang; Lambertus Klei; Rosa Rademakers; Rohan de Silva; Irene Litvan; David E Riley; John C van Swieten; Peter Heutink; Zbigniew K Wszolek; Ryan J Uitti; Jana Vandrovcova; Howard I Hurtig; Rachel G Gross; Walter Maetzler; Stefano Goldwurm; Eduardo Tolosa; Barbara Borroni; Pau Pastor; Laura B Cantwell; Mi Ryung Han; Allissa Dillman; Marcel P van der Brug; J Raphael Gibbs; Mark R Cookson; Dena G Hernandez; Andrew B Singleton; Matthew J Farrer; Chang-En Yu; Lawrence I Golbe; Tamas Revesz; John Hardy; Andrew J Lees; Bernie Devlin; Hakon Hakonarson; Ulrich Müller; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-06-19       Impact factor: 38.330

7.  Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease.

Authors:  Dulal Panda; Jonathan C Samuel; Michelle Massie; Stuart C Feinstein; Leslie Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

8.  Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus.

Authors:  Tara M Caffrey; Catharine Joachim; Richard Wade-Martins
Journal:  Neurobiol Aging       Date:  2007-06-28       Impact factor: 4.673

9.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Authors:  Amanda J Myers; Alan M Pittman; Alice S Zhao; Kristen Rohrer; Mona Kaleem; Lauren Marlowe; Andrew Lees; Doris Leung; Ian G McKeith; Robert H Perry; Chris M Morris; John Q Trojanowski; Christopher Clark; Jason Karlawish; Steve Arnold; Mark S Forman; Vivianna Van Deerlin; Rohan de Silva; John Hardy
Journal:  Neurobiol Dis       Date:  2006-12-15       Impact factor: 5.996

10.  MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies.

Authors:  Daniah Trabzuni; Selina Wray; Jana Vandrovcova; Adaikalavan Ramasamy; Robert Walker; Colin Smith; Connie Luk; J Raphael Gibbs; Allissa Dillman; Dena G Hernandez; Sampath Arepalli; Andrew B Singleton; Mark R Cookson; Alan M Pittman; Rohan de Silva; Michael E Weale; John Hardy; Mina Ryten
Journal:  Hum Mol Genet       Date:  2012-06-20       Impact factor: 6.150
  10 in total
  14 in total

1.  Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes.

Authors:  Maria Elena Di Battista; Esterina Pascale; Carlo Purcaro; Francesca Passarelli; Emanuela Passarelli; Renzo Guglielmi; Nicola Vanacore; Giuseppe Meco
Journal:  J Neural Transm (Vienna)       Date:  2013-11-20       Impact factor: 3.575

Review 2.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

3.  PTL-1 regulates neuronal integrity and lifespan in C. elegans.

Authors:  Yee Lian Chew; Xiaochen Fan; Jürgen Götz; Hannah R Nicholas
Journal:  J Cell Sci       Date:  2013-03-22       Impact factor: 5.285

Review 4.  The neurogenetics of atypical parkinsonian disorders.

Authors:  Brent L Fogel; Mary C Clark; Daniel H Geschwind
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

5.  Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease.

Authors:  Suzee E Lee; Maria C Tartaglia; Görsev Yener; Sermin Genç; William W Seeley; Pascual Sanchez-Juan; Fermin Moreno; Mario F Mendez; Eric Klein; Rosa Rademakers; Adolfo López de Munain; Onofre Combarros; Joel H Kramer; Robert O Kenet; Adam L Boxer; Michael D Geschwind; Maria-Luisa Gorno-Tempini; Anna M Karydas; Gil D Rabinovici; Giovanni Coppola; Daniel H Geschwind; Bruce L Miller
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Oct-Dec       Impact factor: 2.703

6.  An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.

Authors:  Yun Li; Jason A Chen; Renee L Sears; Fuying Gao; Eric D Klein; Anna Karydas; Michael D Geschwind; Howard J Rosen; Adam L Boxer; Weilong Guo; Matteo Pellegrini; Steve Horvath; Bruce L Miller; Daniel H Geschwind; Giovanni Coppola
Journal:  PLoS Genet       Date:  2014-03-06       Impact factor: 5.917

Review 7.  Alpha-synuclein and tau: teammates in neurodegeneration?

Authors:  Simon Moussaud; Daryl R Jones; Elisabeth L Moussaud-Lamodière; Marion Delenclos; Owen A Ross; Pamela J McLean
Journal:  Mol Neurodegener       Date:  2014-10-29       Impact factor: 14.195

Review 8.  Impaired intracellular trafficking defines early Parkinson's disease.

Authors:  Benjamin H M Hunn; Stephanie J Cragg; J Paul Bolam; Maria-Grazia Spillantini; Richard Wade-Martins
Journal:  Trends Neurosci       Date:  2015-01-29       Impact factor: 13.837

Review 9.  Interactions of pathological proteins in neurodegenerative diseases.

Authors:  Tara L Spires-Jones; Johannes Attems; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2017-04-11       Impact factor: 17.088

10.  Regulation of age-related structural integrity in neurons by protein with tau-like repeats (PTL-1) is cell autonomous.

Authors:  Yee Lian Chew; Xiaochen Fan; Jürgen Götz; Hannah R Nicholas
Journal:  Sci Rep       Date:  2014-06-05       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.